Magne B6 forte, 40 pcs.

Weakness and fatigue,Cramps of the calf muscles,GI spasms

Established magnesium deficiency, isolated or associated with other deficiency conditions, accompanied by symptoms such as:

• high irritability,
• significant sleep disturbances,
• gastrointestinal cramps,
frequent palpitations,
• excessive fatigue,
• muscle pain and cramps,
• a tingling sensation in the muscles.

If there is no reduction in these symptoms after one month of treatment, it is not advisable to continue treatment.

Indications

Established magnesium deficiency, isolated or associated with other deficiency conditions, accompanied by symptoms such as:

increased irritability,
minor sleep disturbances,
gastrointestinal spasms,
rapid heartbeat,
increased fatigue,
pain and muscle spasms,
tingling sensation in the muscles.

If after a month of treatment there is no improvement in these symptoms, continuing treatment is not advisable.

Pharmacological effect

Pharmacodynamics

Special instructions

The tablets are intended only for adults and children over 6 years of age.

Active ingredient

Magnesium, Pyridoxine

Composition

1 tablet contains

Tablet core:

active ingredients:
magnesium citrate – 618.43 mg, which corresponds to 100 mg of magnesium (mg++),
pyridoxine hydrochloride – 10.00 mg;
excipients:
lactose – 50.57 mg,
macrogol-6000 – 120.00 mg,
magnesium stearate – 1.00 mg.

Tablet shell:

hypromellose 6 mPa.s – 14.08 mg,
macrogol-6000 – 1.17 mg,
titanium dioxide (E 171) – 4.75 mg,
talc – traces.

Contraindications

Hypersensitivity to the components of the drug.
Severe renal failure (creatinine clearance less than 30 ml/min).
Phenylketonuria.
Age up to 6 years (efficacy and safety have not been established).
Hereditary galactosemia, glucose and galactose malabsorption syndrome, or lactase deficiency (due to the presence of lactose in the drug).
Concomitant use of levodopa (see “Interaction with other drugs”).

With caution

Moderate renal failure (risk of developing hypermagnesemia).

Side Effects

Immune system disorders:

Interaction

Contraindicated combinations

With levodopa: the activity of levodopa is inhibited by pyridoxine (unless this drug is combined with the use of peripheral aromatic L-amino acid decarboxylase inhibitors). Any amount of pyridoxine should be avoided unless levodopa is taken in combination with peripheral aromatic L-amino acid decarboxylase inhibitors.

Combinations not recommended

The simultaneous use of drugs containing phosphates or calcium salts may impair the absorption of magnesium in the intestine.

Combinations to Consider

When prescribing tetracyclines orally, it is necessary to maintain an interval of at least three hours between ingestion of tetracycline and Magne B6, since magnesium preparations reduce the absorption of tetracyclines.

Overdose

Symptoms

Storage conditions

Store at a temperature not exceeding 30 °C.

Shelf life

2 years.

Manufacturer

Opella Healthcare Hungary Ltd., Hungary